vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and Hims & Hers Health, Inc. (HIMS). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $329.5M, roughly 1.9× Andersons, Inc.). Andersons, Inc. runs the higher net margin — 20.5% vs 3.3%, a 17.1% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -2.4%). Hims & Hers Health, Inc. produced more free cash flow last quarter ($-2.5M vs $-77.1M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
ANDE vs HIMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $617.8M |
| Net Profit | $67.4M | $20.6M |
| Gross Margin | 70.3% | 71.9% |
| Operating Margin | 26.6% | 1.5% |
| Net Margin | 20.5% | 3.3% |
| Revenue YoY | -2.4% | 28.4% |
| Net Profit YoY | 49.6% | -20.8% |
| EPS (diluted) | — | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $329.5M | $617.8M | ||
| Q3 25 | $295.8M | $599.0M | ||
| Q2 25 | $535.0M | $544.8M | ||
| Q1 25 | $370.8M | $586.0M | ||
| Q4 24 | $337.5M | $481.1M | ||
| Q3 24 | $231.9M | $401.6M | ||
| Q2 24 | $492.5M | $315.6M | ||
| Q1 24 | $341.4M | $278.2M |
| Q4 25 | $67.4M | $20.6M | ||
| Q3 25 | $20.1M | $15.8M | ||
| Q2 25 | $7.9M | $42.5M | ||
| Q1 25 | $284.0K | $49.5M | ||
| Q4 24 | $45.1M | $26.0M | ||
| Q3 24 | $27.4M | $75.6M | ||
| Q2 24 | $36.0M | $13.3M | ||
| Q1 24 | $5.6M | $11.1M |
| Q4 25 | 70.3% | 71.9% | ||
| Q3 25 | 57.8% | 73.8% | ||
| Q2 25 | 29.6% | 76.4% | ||
| Q1 25 | 41.2% | 73.5% | ||
| Q4 24 | 63.1% | 76.8% | ||
| Q3 24 | 76.4% | 79.2% | ||
| Q2 24 | 35.6% | 81.3% | ||
| Q1 24 | 37.6% | 82.4% |
| Q4 25 | 26.6% | 1.5% | ||
| Q3 25 | 8.7% | 2.0% | ||
| Q2 25 | 4.6% | 4.9% | ||
| Q1 25 | 0.9% | 9.9% | ||
| Q4 24 | 19.9% | 3.9% | ||
| Q3 24 | 26.8% | 5.6% | ||
| Q2 24 | 11.6% | 3.5% | ||
| Q1 24 | 4.1% | 3.6% |
| Q4 25 | 20.5% | 3.3% | ||
| Q3 25 | 6.8% | 2.6% | ||
| Q2 25 | 1.5% | 7.8% | ||
| Q1 25 | 0.1% | 8.4% | ||
| Q4 24 | 13.4% | 5.4% | ||
| Q3 24 | 11.8% | 18.8% | ||
| Q2 24 | 7.3% | 4.2% | ||
| Q1 24 | 1.6% | 4.0% |
| Q4 25 | — | $0.08 | ||
| Q3 25 | $0.59 | $0.06 | ||
| Q2 25 | $0.23 | $0.17 | ||
| Q1 25 | $0.01 | $0.20 | ||
| Q4 24 | $1.31 | $0.10 | ||
| Q3 24 | $0.80 | $0.32 | ||
| Q2 24 | $1.05 | $0.06 | ||
| Q1 24 | $0.16 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $228.6M |
| Total DebtLower is stronger | $560.0M | — |
| Stockholders' EquityBook value | $1.2B | $540.9M |
| Total Assets | $3.7B | $2.2B |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.3M | $228.6M | ||
| Q3 25 | — | $345.8M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $273.7M | ||
| Q4 24 | $561.8M | $220.6M | ||
| Q3 24 | — | $165.5M | ||
| Q2 24 | — | $129.3M | ||
| Q1 24 | — | $105.2M |
| Q4 25 | $560.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $608.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $540.9M | ||
| Q3 25 | $1.2B | $581.0M | ||
| Q2 25 | $1.4B | $562.7M | ||
| Q1 25 | $1.4B | $549.3M | ||
| Q4 24 | $1.4B | $476.7M | ||
| Q3 24 | $1.3B | $440.1M | ||
| Q2 24 | $1.3B | $362.0M | ||
| Q1 24 | $1.3B | $344.5M |
| Q4 25 | $3.7B | $2.2B | ||
| Q3 25 | $3.3B | $2.2B | ||
| Q2 25 | $3.4B | $1.9B | ||
| Q1 25 | $3.8B | $891.7M | ||
| Q4 24 | $4.1B | $707.5M | ||
| Q3 24 | $3.4B | $602.3M | ||
| Q2 24 | $3.3B | $480.5M | ||
| Q1 24 | $3.3B | $448.1M |
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | $61.3M |
| Free Cash FlowOCF − Capex | $-77.1M | $-2.5M |
| FCF MarginFCF / Revenue | -23.4% | -0.4% |
| Capex IntensityCapex / Revenue | 21.5% | 10.3% |
| Cash ConversionOCF / Net Profit | -0.09× | 2.98× |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | $57.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.2M | $61.3M | ||
| Q3 25 | $233.9M | $148.7M | ||
| Q2 25 | $299.3M | $-19.1M | ||
| Q1 25 | $-350.0M | $109.1M | ||
| Q4 24 | $268.8M | $86.4M | ||
| Q3 24 | $-2.1M | $85.3M | ||
| Q2 24 | $304.4M | $53.6M | ||
| Q1 24 | $-239.6M | $25.8M |
| Q4 25 | $-77.1M | $-2.5M | ||
| Q3 25 | $167.0M | $79.3M | ||
| Q2 25 | $250.5M | $-69.5M | ||
| Q1 25 | $-396.6M | $50.1M | ||
| Q4 24 | $212.9M | $59.5M | ||
| Q3 24 | $-40.0M | $79.4M | ||
| Q2 24 | $275.8M | $47.6M | ||
| Q1 24 | $-266.4M | $11.8M |
| Q4 25 | -23.4% | -0.4% | ||
| Q3 25 | 56.5% | 13.2% | ||
| Q2 25 | 46.8% | -12.8% | ||
| Q1 25 | -106.9% | 8.5% | ||
| Q4 24 | 63.1% | 12.4% | ||
| Q3 24 | -17.2% | 19.8% | ||
| Q2 24 | 56.0% | 15.1% | ||
| Q1 24 | -78.0% | 4.3% |
| Q4 25 | 21.5% | 10.3% | ||
| Q3 25 | 22.6% | 11.6% | ||
| Q2 25 | 9.1% | 9.3% | ||
| Q1 25 | 12.6% | 10.1% | ||
| Q4 24 | 16.6% | 5.6% | ||
| Q3 24 | 16.3% | 1.5% | ||
| Q2 24 | 5.8% | 1.9% | ||
| Q1 24 | 7.8% | 5.0% |
| Q4 25 | -0.09× | 2.98× | ||
| Q3 25 | 11.61× | 9.43× | ||
| Q2 25 | 38.10× | -0.45× | ||
| Q1 25 | -1232.46× | 2.20× | ||
| Q4 24 | 5.96× | 3.32× | ||
| Q3 24 | -0.08× | 1.13× | ||
| Q2 24 | 8.46× | 4.03× | ||
| Q1 24 | -42.94× | 2.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
HIMS
Segment breakdown not available.
